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Abstract
Purpose Evidence accumulates that an active lifestyle positively influences cancer treatment outcome. A Bsmartphone
application^ (app) such as BRunKeeper,^ to self-monitor physical activity (PA) might be helpful. This study aimed to examine
whether using RunKeeper to increase self-reported PA is feasible in cancer patients and to evaluate patients’ opinion about using
RunKeeper in a 12-week program.
Methods Adult patients (n = 32), diagnosed with cancer, were randomized between usual care (n = 16) or a 12-week intervention
with instructions to self-monitor PAwith RunKeeper (n = 16). Changes in PAwere determined with the Physical Activity Scale
for the Elderly (PASE) at baseline (T0), 6 weeks (T1), and 12 weeks (T2). Usability and patients’ experiences were tested at T2
with the System Usability Scale (SUS) and a semi-structured interview.
Results Patient mean age was 33.6 years. Between T0 and T1, an increase in PA of 51% (medium estimated effect size r = 0.40)
was found in PASE sum score in the intervention group compared with usual care. In addition, total minutes of PA increased with
46% (r = 0.37). These effects decreased over time (T2). Sedentary time decreased with 19% between T0 and T1 and 27%
between T0 and T2. Usability was rated Bgood^ and most patients found RunKeeper use helpful to improve PA.
Conclusions Self-monitoring PA with RunKeeper was safe and feasible in cancer patients. The RunKeeper use resulted in an
increase in PA after 6 weeks. RunKeeper usability was rated good and can be used to study PA in cancer patients.
Trial registration NCT02391454
Keywords Cancer . Physical activity . Smartphone application . Exercise . RunKeeper . Self-monitoring . Healthy lifestyle
Introduction
In the USA, it is estimated that approximately 60% of yearly
cancer deaths are preventable [1, 2]. In the last decades, to-
bacco use, obesity, sun exposure, infectious agents, and diet
are associated with the development of cancer [1, 2].
Approximately 30% of cancer deaths in the USA can be
accredited to tobacco use [3], an additional one third by being
overweight or obese in combination with physical inactivity
and an unhealthy diet [2, 4, 5].
Therefore, a healthy lifestyle, e.g., smoking cessation, in-
creasing physical activity (PA), protection against sun expo-
sure, a healthy diet, can be considered as primary prevention
of cancer [6, 7]. In addition, evidence accumulates that life-
style influences cancer treatment outcome, and changes the
recurrence rates of the disease [8]. Several studies indicate that
weight gain after cancer treatment increases the risk of cancer
recurrence and cancer-related mortality [4, 9]. Moreover, an
increase in PA might decrease cancer-related mortality
[10–12]. Maintaining PA during active cancer treatment ap-
pears to be safe and feasible, reduces cancer-related fatigue,
limits weight gain, and increases quality of life (QoL) [13].
Unfortunately, cancer patients have a tendency to decrease
their PA due to impaired cardiopulmonary function,
diminishing skeletal muscles, and cancer-related fatigue [14,
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15]. Over the last two decades, several studies examined
whether PA programs could reduce or prevent these negative
effects of cancer treatment [13, 16, 17]. PA programs have
proven to enhance patients’ physical fitness, with improving
QoL and reducing cancer-related fatigue [18, 19].
Studies among cancer patients and survivors regularly en-
counter difficulties in recruiting and retaining patients in PA
programs [20, 21]. Furthermore, patients experience difficul-
ties in remaining physically active after completion of partic-
ipation in a PA program. This might be due to lack of moti-
vation or coaching [22]. A smartphone application (app) may
be a low-threshold tool to counteract these problems [23].
Universally, smartphones are widespread and incorporated in
our daily living. Various studies that examined apps designed
to self-monitor PA showed promising results in improving PA
[24–27]. However, none of these studies examined an app to
self-monitor PA in cancer patients.
Therefore, the primary aim of this study was to determine
the feasibility of the RunKeeper app use on self-reported PA
during and after cancer treatment in comparison with usual
care in a 12-week follow-up. The secondary aim was to ex-




This feasibility study was conducted at the UniversityMedical
Center Groningen (UMCG) in Groningen, The Netherlands.
From February until April 2015, adult cancer patients who
received systemic cancer treatment with curative intent, or in
the follow-up period (cancer survivors), were recruited and
enrolled at the department of Medical Oncology. Eligibility
criteria included patients diagnosed with cancer (regardless of
type/staging) ≥ 18 years of age with a World Health
Organization (WHO)-performance score ≤ 1. Patients were
not eligible when they were unable to read or comprehend
the Dutch language, unable to handle or were not in pos-
session of a smartphone, diagnosed with a cardiac illness,
psychiatric illness, severe kidney or liver impairment, pan-
cytopenia or when they were participating in a supervised
PA program.
RunKeeper app
The BRunKeeper app,^ RunKeeper version 4.8.1, founded by
Mr. Jason Jacobs, 2008, FitnessKeeper Inc. (RunKeeper) is a
free, widely spread and well-known app for self-monitoring
PA with over 26 million users on the smartphone so called
platforms Android and iPhone’s iOS. In a recent review,
RunKeeper was rated best on using behavioral change tech-
niques to stimulate a healthy lifestyle [28].
Study procedure
Eligible patients were identified by the investigator who
screened the medical records of patients from the Medical
Oncology department of the UMCG. After a hospital visit,
the investigator informed eligible patients with permission of
their treating oncologist. Patients were given an information
letter with an attached informed consent form in twofold and a
pre-paid return envelope. When there was no response within
1 week, the investigator contacted the corresponding patient.
After written informed consent was obtained, patients were
equally divided by computerized randomization in a 1:1 ratio
to BGroup A,^ intervention group or BGroup B,^ control
group. Patients randomized in Group A received a brief user’s
guide for the RunKeeper app use and were instructed to self-
monitor PA (see Appendix).
Usual care and study intervention
In the UMCG, all patients who are currently treated for cancer
or in follow-up are informed that regular PA during and after
multimodality cancer treatment is safe, feasible and enhances
recovery and physical health. Patients are advised to stay
physically active for at least 30 min per day, 5 days per week.
This is care as usual. Patients randomized in Group B were
advised according to usual care. Patients in the intervention
group, Group A, were additionally instructed to self-monitor
PA (e.g., cycling, hiking, running) by GPS or stopwatch with
RunKeeper. Furthermore, patients were requested to activate
the Btraining reminder^ option in the RunKeeper app. One
investigator (HO)was available for answering questions about
the RunKeeper use by telephone or e-mail.
Measurements
At T0, medical characteristics (treatment status, end of sys-
temic cancer treatment (months) and cancer type) were obtain-
ed by reviewing patients’ medical record and socio-demo-
graphic, physical and behavioral characteristics (age, gender,
marital status, BMI, smoking habits and alcohol consumption)
were gathered by a short self-report questionnaire. Alcohol
consumption was classified as non-drinker, occasional drinker
(alcohol intake < 3 beverages/week), light regular drinker (al-
cohol intake ≥ 3 but < 6 beverages/week), moderate regular
drinker (≥ 6 beverages/week) and excessive drinker (alcohol
intake ≥ 14 beverages/week for women and ≥ 21 for men)
[29]. Patient-reported outcome (PRO) was evaluated at base-
line [T0], 6 weeks [T1], and after 12 weeks [T2], in both the
control and intervention group (see Supplementary Fig. S1 for
the design of the SMART-trial). Patients were contacted by a
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telephone call to return the questionnaires when there was no
response within 1 week after each measurement. Adverse
events (intervention-related) were closely monitored by inves-
tigators during the course of the study.
PRO’s included the validated (Dutch) translated Physical
Activity Scale for the Elderly (PASE) questionnaire, a 7-day
recall questionnaire [30, 31]. The PASE is designed to mea-
sure PA extensively by identifying leisure-time-, house-
hold-, and work-related activities. The three subscales of
the PASE questionnaire, PASE sum score, total minutes of
PA (minutes/week), and sedentary time (minutes/week),
were classified to be valuable for clinical practice with a
small standard error of measurement (SEM) [31]. In addi-
tion, the PASE sum score and total minutes of PA were
subdivided in leisure-time PA [32].
At T2, each patient of Group A filled out the (Dutch) trans-
lated validated System Usability Scale (SUS) to measure the
usability of the RunKeeper app [33]. The SUS is a standard-
ized 10 item questionnaire to quantify the usability of the used
systems (RunKeeper app) in terms of effectiveness, efficacy,
and satisfaction [33].
In addition, patients in Group A were questioned about
how they experienced the RunKeeper use in a semi-
structured interview by telephone. Medical records were
screened and one investigator (HO) asked if any adverse
events occurred during the 12-week intervention and three
questions regarding how patients experienced the
RunKeeper use. These three questions were: BHow did you
experience the RunKeeper app use?^ BHow frequent did u use
the RunKeeper app and are you planning to continue using
RunKeeper?^ and BDid you become more physically active
due to the use of RunKeeper?^
Statistical analysis
Data from T0, 1 and 2 within groups and between both groups
were analyzed. The Shapiro-Wilk normality test and Q-Q
plots were used to evaluate whether continuous data was nor-
mally distributed. Between groups, comparisons were per-
formed using independent samples T tests or Mann-Whitney
U tests when data was not normally distributed. Means,
pooled standard deviations (SDp) and 95% confidence inter-
vals of the PASE subscales were calculated. When the data
was not normally distributed, the medians and associated inter
quartile ranges were calculated. Estimated effect sizes were
calculated using the formula of Cohen’s d and Pearson’s cor-
relation coefficient r for the interpretability and were classified
as described by the guidelines of Cohen, et al. with 0.20, 0.50
and 0.80 for Bsmall,^ Bmedium^ and Blarge^ effects, respec-
tively [34]. IBM SPSS Statistics package for Mac (version
22.0, SPSS Inc., Chicago, USA) was used to analyze data.
The score of the usability questionnaire SUS was calculated
with mean, SDp and 95% confidence intervals or median with




In total, 78 patients were assessed for eligibility by screening
the medical records of patients visiting the Medical Oncology
department of the UMCG. Nine patients did not have a
smartphone, one patient was participating in oncologic reha-
bilitation and one was an active user of the RunKeeper app
(see Fig. 1). Seven were ineligible due to medical reasons. Of
the 60 eligible patients, 28 declined (too busy n = 4, already
active n = 5, no reply n = 4 and not interested n = 15) and 32
agreed to participate. Patients were randomized in Group A,
intervention group (n = 16) or Group B (n = 16), control
group. No adverse events related to the study intervention
occurred.
Effect of intervention on outcomes
Baseline characteristics of both groups were well balanced
(see Table 1). Of the 32 patients included in the analysis,
87.5% was male, the median age was 33.6 years. All patients
were treated with a curative intent. At baseline, four patients
were still receiving systemic cancer treatment. The majority of
patients (n = 23) was in follow-up after systemic cancer treat-
ment, with a median of 22 months after completing systemic
cancer treatment (inter quartile range = 35.5). The average
BMI of patients was 25.7 kg/m2. The majority of patients
(75%) was unmarried.
One patient randomized in the intervention group was un-
able to use RunKeeper, due to the possession of an iPhone 3,
the new RunKeeper version was compatible only for models
iPhone 4 or higher. At baseline, there were no significant
differences in self-reported PA between groups as measured
by the three subscales of the PASE: PASE sum score, total
minutes of PA and sedentary time (Table 2).
Median scores and effect sizes of different subscales of the
PASE questionnaire at T0, T1, and T2, which were completed
by all patients of both groups (n = 32) are presented in Table 3.
The intervention group as compared to the control group
showed a significant increase in self-reported PA of 51% from
T0 to T1, as measured by the subscale PASE sum score (r =
0.40). The leisure-time PA scores are displayed in
Supplementary Table S2. A similar result was observed by
the PASE subscale total minutes of PA, which indicated that
patients’ total minutes of weekly PA increased significantly by
46% compared to the control group (r = 0.37). Though, these
improvements were not sustained at T2. Analysis of the
subscale sedentary time between T0 and T1 revealed a
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19% difference in decrease of patients’ sedentary time
which favored the intervention group (r = 0.071).
Between T0 and T2, the difference in sedentary time in-
creased to 27% (r = 0.11).
The usability of the RunKeeper app was quantitatively and
qualitatively analyzed. At T2, 15 patients in Group A rated the
usability as measured by the SUS, mean = 79.3 (SDp = 13.1;
95% confidence interval = 72.1–86.6). In addition, 14 qualita-
tive semi-structured interviews were performed (see
Supplementary Table S3). Two patients did not respond on
our telephone calls and did not participate in this part. Most
patients (n = 12) were enthusiastic about the RunKeeper app
use. Eleven patients were still frequently using the RunKeeper
app to self-monitor PA at T2. Majority of patients (n = 8)
became more active due to the RunKeeper use and were plan-
ning to continue the use of RunKeeper.
Discussion
This study clearly demonstrates the feasibility of self-
monitoring PA with the RunKeeper app in cancer patients
and survivors in a 12-week program. Cancer patients and sur-
vivors were enthusiastic about the use of the RunKeeper app
and found its use of additional value to care as usual. This
exploratory study was not powered to detect differences be-
tween both groups.
Despite the accumulating evidence of importance of PA
in cancer treatment, studies reveal that recruiting and
retaining patients in PA programs is challenging [13, 20].
Possible hurdles are the intensity and frequency of training
sessions, being unfamiliar with PA, travel distances and
being too busy (work, children at home) [35]. There is an
urgent need of low-threshold approaches to improve and
Assessed for eligibility (n = 60) 
Excluded  (n = 28) 
Not interested (n = 15) 
Already active (n = 5) 
Too busy (n = 4) 
No reply (n = 4) 
Already active (n = 5)
Analysis, Intent to Treat 
Analyzed (n =16)
Lost to follow-up (n = 0) 
Discontinued intervention (iPhone 3 was 
incompatible for using the RunKeeper app)  
(n = 1)
Allocated to intervention group (n = 16) 
Received allocated intervention (n = 15)
Did not receive allocated intervention 
(iPhone 3 was incompatible for using the 
RunKeeper app) (n = 1)
Lost to follow-up (n = 0) 
Discontinued care as usual (n = 0) 
Allocated to control group (n = 16) 
Received care as usual (n = 16)
Did not receive care as usual (n = 0)





Randomized (n = 32) 
Enrollment
Screened prior to eligibility 
assessment (n = 78) Excluded  (n = 18) 
No smartphone (n =  9) 
Severe heart disease (n = 1) 
Severe kidney disease (n = 1) 
PS>1 (n = 5) 
Active RunKeeper user (n = 1) 
Following PA rehabilitation (n =1) 
Screened
Fig. 1. Flowchart of the SMART-trial (n = 32). PA, physical activity; PS, performance score; app, smartphone application
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sustain PA in patients diagnosed with cancer. Our results
provide information to further develop PA programs for
cancer patients and survivors. Patients increased their PA
by using the RunKeeper app compared to usual care from
baseline to 6 weeks as measured by the PASE sum score
and total minutes of PA. However, no difference was de-
tected between baseline and 12 weeks. This phenomenon
might be due to the novelty of using the RunKeeper app,
which diminishes over time and reduces interest in using
the app to self-monitor PA [27]. In addition, patients ran-
domized to the control group were expected to slightly
increase their PA due to the participation in a study and
the PA advice given as care as usual. The usability of
RunKeeper was scored Bgood^ as measured by the SUS,
which was endorsed by the findings of the qualitative
semi-structured interview.
Table 1 PA at baseline as measured by the PASE in the SMART-trial (n = 32)
IG (n = 16) CG (n = 16)
Characteristic No. % No. %
Demographic characteristics




Male 14 87.5 14 87.5
Female 2 12.5 2 12.5







Non-smoker 14 87.5 16 100
Smoker 2 12.5 0 0
Alcohol consumption
Non-drinker 4 25.0 5 31.3
Occasional drinker 2 12.5 1 6.3
Light regular drinker 5 31.3 6 37.5
Moderate regular drinker 4 25.0 3 18.8
Excessive drinker 1 6.3 1 6.3
Medical characteristics
Treatment status
Active systemic cancer treatment 2 12.5 2 12.5
Follow-up 13 81.3 10 62.5
No systemic cancer treatment 1 6.3 4 25.0




Testicular cancer 14 87.5 13 81.3
Breast cancer 2 12.5 2 12.5
Osteosarcoma 0 0 1 6.3
Differences between both groups were assessed by independent samples T tests when data was continuous, Mann-Whitney U tests when data was not
normally distributed and chi-squared tests or Fisher’s exact test with categorical data with two-sided P values (*P ≤ 0.05; **P ≤ 0.01)
Abbreviations: IG, intervention group; CG, control group; SD, standard deviation; BMI, body mass index; IQR, inter quartile range
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The current study has several limitations. First, PA was
measured by a self-report questionnaire, which is less optimal
as compared to an objective measurement, like accelerometry
[31]. In addition, patients could have overestimated or
underestimated their self-reported PA and the measurement
of PA with a 7-day recall questionnaire could have been
biased by recall. Potentially, measurement of PA deviations
caused by the use of the RunKeeper app were confounded
by the components Bhousehold^-, and Bwork-related
activities,^ which are part of the measurement of self-
reported PA by the PASE questionnaire [32]. In future
studies, it might be worthwhile to consider household in-
come and employment status.
Over the last few years, studies showed that self-monitoring
PA with an app could improve PA [24–27]. Though, less is
known about the use of publicly available smartphone apps
to stimulate PA in cancer patients. Recently, Puszkiewicz, et
al. [36] showed that the use of a publicly available app
BGAINFitness^ to self-monitor strengthening exercises during
6 weeks was positively received and used by small population
of cancer survivors (n = 11). The positive attitude of patients
against using an app to self-monitor PA is corresponding with
findings in our study.
The scores of the PASE questionnaire subscales in our
study population at baseline are comparable with other studies
that used the PASE in patients with hip osteoarthritis [37],
knee pain, ischemic stroke [38] and cancer [31]. A recent
qualitative study showed that patients are interested and en-
thusiastic about the use of apps, which is in line with findings
of our study [39]. However, the median age of patients that
participated in the study of 33.6 years is low in comparison
with the average age of cancer patients. Probably, the high
number of patients with testicular cancer resulted in this youn-
ger age of the study population, which limits the generaliz-
ability. Cancer patients of older age might encounter difficul-
ties in using advanced technological devices.
Furthermore, there were no additional costs and there
was no travel burden for patients by participation in this
Table 2 Outcome PASE questionnaire at baseline (n = 32)
IG (n = 16) CG (n = 16) Pa Quartiles of the Dif.
PASE subscales Mdn IQR Mdn IQR Q1 Q3
PASE sum score (score) 133 102 116 172 0.851 76.8 188
Total minutes of PA (min/wk) 2693 2096 2498 3218 0.546 1534 3776
Sedentary time (min/wk) 735 540 630 979 0.985 540 1080
aDifferences between both groups were assessed by Mann-Whitney U tests with two-sided P values (*P ≤ 0.05; **P ≤ 0.01)
Abbreviations: IG, intervention group; CG, control group; PASE, Physical Activity Scale for the Elderly; PA, physical activity; min, minutes; wk., week;
Mdn, median; Dif., difference; IQR, inter quartile range; Q1 , 25th quartile; Q3 , 75th quartile
Table 3 PA change scores as measured by the PASE in the SMART-trial (n = 32)
Δ IG versus CG median change with IQR
Baseline (T0) Week 6 (T1) Week 12 (T2) 6 weeks (T0–T1) 12 weeks (T0–T2)
PASE subscales Mdn IQR Mdn IQR Mdn IRQ Mdn Q1 to Q3 Pa Mdn Q1 to Q3 Pa
PASE sum score (score)
IG (n = 16) 133 102 206 87.7 175 176 12.1 − 31.2 to 73.9 0.024* 8.84 − 68.0 to 92.6 0.651
CG (n = 16) 116 172 121 97.8 134 92
Total minutes of PA (min/wk)
IG (n = 16) 2693 2096 3773 2351 2843 2565 345 − 660 to 1376 0.038* − 105 − 1144 to 1605 0.763
CG (n = 16) 2498 3218 2348 1568 2490 1405
Sedentary time (min/wk)
IG (n = 16) 735 540 540 1181 540 1215 0 − 394 to 0 0.686 0 − 416 to 0 0.532
CG (n = 16) 630 979 585 799 630 900
aDifferences between both groups were assessed by Mann-Whitney U tests with two-sided P values (*P ≤ 0.05; **P ≤ 0.01)
Abbreviations: IG, intervention group; CG, control group; PASE, Physical Activity Scale for the Elderly; PA, physical activity; min, minutes; wk., week;
IQR, inter quartile range; Q1 , 25th quartile; Q3 , 75th quartile
3920 Support Care Cancer (2018) 26:3915–3923
study which contributed to the adherence. Travel burden is
one of the main reasons for non-adherence to PA programs
[40]. Potentially, the low-threshold character of our inter-
vention encouraged the less motivated patients to become
more physically active. However, half of eligible patients
decided not to participate in the study due to several rea-
sons. This was also observed in various PA studies across
different cancer patient populations, resulting in lower re-
cruitment rates [17].
In the semi-structured qualitative interview, several pa-
tients mentioned barriers for using the app to self-monitor
PA. Some patients mentioned they forgot to use the app
during their activities. In addition, few patients suggested
that tailored feedback on their PA data would increase their
adherence to the PA program [41]. This in accordance with
findings of Phillips, et al. [42], they explored preferences
of breast cancer survivors with online questionnaires and
found that the majority were interested in using an app to
self-monitor PA and to receive coaching from a distance
with personalized feedback. Healthy, overweight partici-
pants adhered better to a weight loss program when indi-
vidual feedback was provided as compared to participants
who received a link to educational websites only in a
home-based setting [43]. Moreover, tailored feedback
through biweekly telephone calls in addition to self-
monitoring on a mobile system was significantly more ef-
fective in sustained weight loss than the intervention with-
out tailored feedback [44]. Also, both telephone counseling
and coaching are effective weight loss strategies in breast
cancer survivors [45].
In conclusion, this study shows that self-monitoring PA
with RunKeeper is safe and feasible in cancer patients.
Further research is needed to investigate whether the
RunKeeper app use improves and sustains PA in cancer pa-
tients and survivors. The use of RunKeeper is of clinical in-
terest as a low-threshold tool to stimulate PA in cancer patients
in a home-based setting.
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